Both in Pharmaceuticals
Capricor Therapeutics vs Evolus
Over the past year CAPR returned +47.2% and EOLS returned +16.5%; their daily moves had a correlation of 0.09.
CAPR +47.2% EOLS +16.5%Growth of $1, one year, split-adjusted
| Metric | CAPR | EOLS |
|---|---|---|
| Price | $8.92 | $7.47 |
| Market cap | $518.6M | $493.4M |
| Today | +8.25% | +1.36% |
| 1 month | +15.1% | +1.2% |
| 6 months | −74.1% | +18.2% |
| Year to date | −69.1% | +12.3% |
| 1 year | — | +16.9% |
| Revenue growth (YoY) | — | +21.2% |
| Gross margin | — | 68.0% |
| Net margin | — | −9.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.6× |
| Net cash | $237.9M | -$141.9M |
| Dividend yield | — | — |
| Volatility (60d) | 144.1% | 48.9% |
| Short % of float | 48.4% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).